Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.
Katrine BaumannAstrid-Helene Ravn JørgensenJennifer Astrup SørensenDitte Georgina ZhangMisbah Noshela GhazanfarPer Stahl SkovAnders WoetmannChristian VestergaardMarcus MaurerSimon Francis ThomsenPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Keyphrases